• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过内脏脂肪组织指数对乙肝相关肝细胞癌(≤5厘米)早期复发进行术前预测

Preoperative prediction of early recurrence of HBV-related hepatocellular carcinoma (≤5 cm) by visceral adipose tissue index.

作者信息

Wu Zong-Qian, Cheng Jie, Xiao Xi-Xi, Zhang Hua-Rong, Wang Jian, Peng Juan, Liu Chen, Cai Ping, Li Xiao-Ming

机构信息

Department of Radiology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.

Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.

出版信息

Front Surg. 2023 Jan 6;9:985168. doi: 10.3389/fsurg.2022.985168. eCollection 2022.

DOI:10.3389/fsurg.2022.985168
PMID:36684155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9852492/
Abstract

BACKGROUND

This study aimed to investigate whether visceral adipose tissue index (VATI) is a significant risk factor for the early recurrence (ER) of HBV-related hepatocellular carcinoma (HCC) (≤5 cm) after hepatectomy.

METHODS

The recruited cohort patients who were positive for hepatitis B virus, presented with surgically confirmed HCC (≤5 cm) from Army Medical University (internal training cohort:  = 192) and Chongqing Medical University (external validation group:  = 46). We measured VATI, subcutaneous adipose tissue index (SATI) computed tomography (CT). ER was defined as recurrence within 2 years after hepatectomy. The impact of parameters on outcome after hepatectomy for HCC was analyzed.

RESULTS

Univariate analysis showed that alpha-fetoprotein levels ( = 0.044), body mass index (BMI) ( < 0.001), SATI ( < 0.001), and VATI ( < 0.001) were significantly different between ER and non-ER groups in internal training cohort. Multivariate analysis identified VATI as an independent risk factor for ER (odds ratio = 1.07, 95% confidence interval: 1.047-1.094,  < 0.001), with a AUC of 0.802, based on the cut-off value of VATI, which was divided into high risk (≥37.45 cm/m) and low risk (<37.45 cm/m) groups. The prognosis of low risk group was significantly higher than that of high risk group (< 0.001). The AUC value of VATI in external validation group was 0.854.

CONCLUSION

VATI was an independent risk factor for the ER, and higher VATI was closely related to poor outcomes after hepatectomy for HBV-related HCC (≤5 cm).

摘要

背景

本研究旨在探讨内脏脂肪组织指数(VATI)是否是乙肝相关肝细胞癌(HCC)(≤5 cm)肝切除术后早期复发(ER)的重要危险因素。

方法

招募来自陆军军医大学(内部训练队列:n = 192)和重庆医科大学(外部验证组:n = 46)的乙肝病毒阳性、经手术确诊为HCC(≤5 cm)的队列患者。我们通过计算机断层扫描(CT)测量VATI、皮下脂肪组织指数(SATI)。ER定义为肝切除术后2年内复发。分析了各参数对HCC肝切除术后结局的影响。

结果

单因素分析显示,内部训练队列中,ER组和非ER组之间的甲胎蛋白水平(P = 0.044)、体重指数(BMI)(P < 0.001)、SATI(P < 0.001)和VATI(P < 0.001)存在显著差异。多因素分析确定VATI是ER的独立危险因素(比值比 = 1.07,95%置信区间:1.047 - 1.094,P < 0.001),基于VATI的截断值,其AUC为0.802,分为高风险(≥37.45 cm/m)和低风险(<37.45 cm/m)组。低风险组的预后显著高于高风险组(P < 0.001)。外部验证组中VATI的AUC值为0.854。

结论

VATI是ER的独立危险因素,较高的VATI与乙肝相关HCC(≤5 cm)肝切除术后的不良结局密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8652/9852492/acfc0acf86ca/fsurg-09-985168-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8652/9852492/488fe2f535af/fsurg-09-985168-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8652/9852492/ed9666520119/fsurg-09-985168-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8652/9852492/ffc2e43ba14d/fsurg-09-985168-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8652/9852492/6d8548fc46f2/fsurg-09-985168-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8652/9852492/acfc0acf86ca/fsurg-09-985168-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8652/9852492/488fe2f535af/fsurg-09-985168-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8652/9852492/ed9666520119/fsurg-09-985168-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8652/9852492/ffc2e43ba14d/fsurg-09-985168-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8652/9852492/6d8548fc46f2/fsurg-09-985168-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8652/9852492/acfc0acf86ca/fsurg-09-985168-g005.jpg

相似文献

1
Preoperative prediction of early recurrence of HBV-related hepatocellular carcinoma (≤5 cm) by visceral adipose tissue index.通过内脏脂肪组织指数对乙肝相关肝细胞癌(≤5厘米)早期复发进行术前预测
Front Surg. 2023 Jan 6;9:985168. doi: 10.3389/fsurg.2022.985168. eCollection 2022.
2
U-shaped relationship between subcutaneous adipose tissue index and mortality in liver cirrhosis.皮下脂肪组织指数与肝硬化患者死亡率之间的 U 型关系。
J Cachexia Sarcopenia Muscle. 2023 Feb;14(1):508-516. doi: 10.1002/jcsm.13154. Epub 2022 Dec 28.
3
Visceral Adipose Tissue Index and Hepatocellular Carcinoma Are Independent Predictors of Outcome in Patients with Cirrhosis Having Endoscopic Treatment for Esophageal Varices.内脏脂肪组织指数和肝细胞癌是肝硬化患者内镜治疗食管静脉曲张后结局的独立预测因素。
Dig Dis. 2021;39(1):58-65. doi: 10.1159/000508867. Epub 2020 May 25.
4
Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant.内脏肥胖增加了肝硬化和肝移植后复发的男性患者发生肝细胞癌的风险。
Hepatology. 2018 Mar;67(3):914-923. doi: 10.1002/hep.29578. Epub 2018 Jan 26.
5
Sarcopenia and visceral adiposity predict poor overall survival in hepatocellular carcinoma patients after curative hepatic resection.肌肉减少症和内脏脂肪过多预示着肝细胞癌患者在根治性肝切除术后总体生存率较差。
Transl Cancer Res. 2021 Feb;10(2):854-866. doi: 10.21037/tcr-20-2974.
6
Assessing Visceral Obesity and Abdominal Adipose Tissue Distribution in Healthy Populations Based on Computed Tomography: A Large Multicenter Cross-Sectional Study.基于计算机断层扫描评估健康人群的内脏肥胖和腹部脂肪组织分布:一项大型多中心横断面研究。
Front Nutr. 2022 Apr 25;9:871697. doi: 10.3389/fnut.2022.871697. eCollection 2022.
7
Higher Accumulation of Visceral Adipose Tissue Is an Independent Risk Factor for Hepatocellular Carcinoma among Viral Hepatitis Patients with Non-Cirrhotic Livers.在非肝硬化的病毒性肝炎患者中,内脏脂肪组织的更高蓄积是肝细胞癌的独立危险因素。
Cancers (Basel). 2021 Nov 28;13(23):5980. doi: 10.3390/cancers13235980.
8
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
9
Increased Visceral Adipose Tissue and Hyperinsulinemia Raise the Risk for Recurrence of Non-B Non-C Hepatocellular Carcinoma after Curative Treatment.内脏脂肪组织增加和高胰岛素血症会增加非B非C型肝细胞癌根治性治疗后复发的风险。
Cancers (Basel). 2021 Mar 26;13(7):1542. doi: 10.3390/cancers13071542.
10
Computed tomography reference values for visceral obesity and increased metabolic risk in a Caucasian cohort.高加索人群内脏型肥胖和代谢风险增加的计算机断层扫描参考值。
Clin Nutr ESPEN. 2022 Apr;48:408-413. doi: 10.1016/j.clnesp.2022.01.009. Epub 2022 Jan 14.

引用本文的文献

1
A novel hybrid model for predicting tertiary lymphoid structures and targeted immunotherapy outcomes in hepatocellular carcinoma: a multicenter retrospective study.一种预测肝细胞癌三级淋巴结构和靶向免疫治疗结果的新型混合模型:一项多中心回顾性研究。
Eur Radiol. 2025 Jun;35(6):3206-3222. doi: 10.1007/s00330-024-11255-9. Epub 2024 Dec 10.
2
Influence of body fat tissue on outcomes in patients undergoing hepatectomy or liver transplantation: a systematic review and meta-analysis.体脂组织对肝切除或肝移植患者预后的影响:一项系统评价和荟萃分析。
Int J Surg. 2025 Jan 1;111(1):1167-1181. doi: 10.1097/JS9.0000000000001864.

本文引用的文献

1
Preoperative Assessment of Abdominal Adipose Tissue to Predict Microvascular Invasion in Small Hepatocellular Carcinoma.腹部脂肪组织的术前评估以预测小肝细胞癌的微血管侵犯
J Clin Transl Hepatol. 2022 Apr 28;10(2):184-189. doi: 10.14218/JCTH.2021.00126. Epub 2021 Jul 7.
2
Increased Visceral Adipose Tissue and Hyperinsulinemia Raise the Risk for Recurrence of Non-B Non-C Hepatocellular Carcinoma after Curative Treatment.内脏脂肪组织增加和高胰岛素血症会增加非B非C型肝细胞癌根治性治疗后复发的风险。
Cancers (Basel). 2021 Mar 26;13(7):1542. doi: 10.3390/cancers13071542.
3
Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC.
血清中循环 microRNA-107 的水平在早期 HCC 患者中升高。
PLoS One. 2021 Mar 12;16(3):e0247917. doi: 10.1371/journal.pone.0247917. eCollection 2021.
4
The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma.微血管侵犯在肝癌手术规划和术后序贯治疗中的临床意义。
Sci Rep. 2021 Jan 28;11(1):2415. doi: 10.1038/s41598-021-82058-x.
5
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).肝细胞癌诊疗指南(2019年版)
Liver Cancer. 2020 Dec;9(6):682-720. doi: 10.1159/000509424. Epub 2020 Nov 11.
6
Nomograms predicting extra- and early intrahepatic recurrence after hepatic resection of hepatocellular carcinoma.列线图预测肝癌肝切除术后肝外和早期肝内复发。
Surgery. 2021 Apr;169(4):922-928. doi: 10.1016/j.surg.2020.10.012. Epub 2020 Nov 13.
7
Prognostic Nomograms for Patients with Hepatocellular Carcinoma After Curative Hepatectomy, with a Focus on Recurrence Timing and Post-Recurrence Management.根治性肝切除术后肝细胞癌患者的预后列线图,重点关注复发时间和复发后管理
J Hepatocell Carcinoma. 2020 Oct 27;7:233-256. doi: 10.2147/JHC.S271498. eCollection 2020.
8
Visceral Adipose Tissue Index and Hepatocellular Carcinoma Are Independent Predictors of Outcome in Patients with Cirrhosis Having Endoscopic Treatment for Esophageal Varices.内脏脂肪组织指数和肝细胞癌是肝硬化患者内镜治疗食管静脉曲张后结局的独立预测因素。
Dig Dis. 2021;39(1):58-65. doi: 10.1159/000508867. Epub 2020 May 25.
9
Molecular Mechanisms Regulating Obesity-Associated Hepatocellular Carcinoma.调控肥胖相关肝细胞癌的分子机制
Cancers (Basel). 2020 May 20;12(5):1290. doi: 10.3390/cancers12051290.
10
Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients.术前预测对单个肝细胞癌患者的早期复发可与术后评估一样准确。
Korean J Radiol. 2020 Apr;21(4):402-412. doi: 10.3348/kjr.2019.0538.